Albeituni S - Search Results

1

JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation.

Meyer LK, Verbist KC, Albeituni S, Scull BP, Bassett RC, Stroh AN, Tillman H, Allen CE, Hermiston ML, Nichols KE. Meyer LK, et al. Among authors: albeituni s. Blood. 2020 Aug 6;136(6):657-668. doi: 10.1182/blood.2020006075. Blood. 2020. PMID: 32530039 Free PMC article.

2

Microbiota-dependent signals are required to sustain TLR-mediated immune responses.

Weaver LK, Minichino D, Biswas C, Chu N, Lee JJ, Bittinger K, Albeituni S, Nichols KE, Behrens EM. Weaver LK, et al. Among authors: albeituni s. JCI Insight. 2019 Jan 10;4(1):e124370. doi: 10.1172/jci.insight.124370. JCI Insight. 2019. PMID: 30626747 Free PMC article.

3

The Immunology of Macrophage Activation Syndrome.

Crayne CB, Albeituni S, Nichols KE, Cron RQ. Crayne CB, et al. Among authors: albeituni s. Front Immunol. 2019 Feb 1;10:119. doi: 10.3389/fimmu.2019.00119. eCollection 2019. Front Immunol. 2019. PMID: 30774631 Free PMC article. Review.

4

Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis.

Albeituni S, Verbist KC, Tedrick PE, Tillman H, Picarsic J, Bassett R, Nichols KE. Albeituni S, et al. Blood. 2019 Jul 11;134(2):147-159. doi: 10.1182/blood.2019000761. Epub 2019 Apr 23. Blood. 2019. PMID: 31015190 Free PMC article.

5

Synergistic Signaling of TLR and IFNα/β Facilitates Escape of IL-18 Expression from Endotoxin Tolerance.

Verweyen E, Holzinger D, Weinhage T, Hinze C, Wittkowski H, Pickkers P, Albeituni S, Verbist K, Nichols KE, Schulert G, Grom A, Foell D, Kessel C. Verweyen E, et al. Among authors: albeituni s. Am J Respir Crit Care Med. 2020 Mar 1;201(5):526-539. doi: 10.1164/rccm.201903-0659OC. Am J Respir Crit Care Med. 2020. PMID: 31710506 Free PMC article.

6

Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.

Keenan C, Nichols KE, Albeituni S. Keenan C, et al. Among authors: albeituni s. Front Immunol. 2021 Feb 16;12:614704. doi: 10.3389/fimmu.2021.614704. eCollection 2021. Front Immunol. 2021. PMID: 33664745 Free PMC article. Review.

7

Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome.

Huarte E, Peel MT, Verbist K, Fay BL, Bassett R, Albeituni S, Nichols KE, Smith PA. Huarte E, et al. Among authors: albeituni s. Front Pharmacol. 2021 Apr 22;12:650295. doi: 10.3389/fphar.2021.650295. eCollection 2021. Front Pharmacol. 2021. PMID: 33981229 Free PMC article.

8

Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis.

Albeituni S, Oak N, Tillman HS, Stroh A, Keenan C, Bloom M, Nichols KE. Albeituni S, et al. Front Immunol. 2023 Apr 27;14:1137037. doi: 10.3389/fimmu.2023.1137037. eCollection 2023. Front Immunol. 2023. PMID: 37228616 Free PMC article.

9

Roles of Ceramides and Other Sphingolipids in Immune Cell Function and Inflammation.

Albeituni S, Stiban J. Albeituni S, et al. Adv Exp Med Biol. 2019;1161:169-191. doi: 10.1007/978-3-030-21735-8_15. Adv Exp Med Biol. 2019. PMID: 31562630 Review.

10

Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo.

Thomas A, Samykutty A, Gomez-Gutierrez JG, Yin W, Egger ME, McNally M, Chuong P, MacCuaig WM, Albeituni S, Zeiderman M, Li M, Edil BH, Grizzle WE, McMasters KM, McNally LR. Thomas A, et al. Among authors: albeituni s. Cancers (Basel). 2020 Aug 14;12(8):2279. doi: 10.3390/cancers12082279. Cancers (Basel). 2020. PMID: 32823919 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters